Towards evidence-based practice via practice-based evidence: The Italian experience

Family Practice

Volumn 25, Issue SUPPL. 1, 2009, Pages

  Visentin, Giorgio ^a  

^a Centro Studi e Richerche in Medicina Generale   (Italy)

Author keywords

Cardiovascular risk prevention; Family medicine; Randomized controlled trail

Indexed keywords

ACARBOSE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; INSULIN; OMEGA 3 FATTY ACID; SULFONYLUREA DERIVATIVE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; EXERCISE; FAMILY MEDICINE; FEEDING BEHAVIOR; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ITALY; LIFESTYLE MODIFICATION; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOPERATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; MALE; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; PUBLIC RELATIONS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; DIABETES MELLITUS; EVIDENCE-BASED PRACTICE; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERINSTITUTIONAL RELATIONS; ITALY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; PROGRAM EVALUATION; QUESTIONNAIRES;

EID: 65849190466     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmn079     Document Type: Conference Paper

References (11)

1. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzionetrial. Lancet 1999; 354: 447-455.
2. Roncaglioni MC. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.
3. Visentin G. on behalf of R&P collaboration group. R&P: the multiple meaning of a research project in general practice. Eur J Clin Nutr 2005; 59 (suppl 1): 589-592.
4. MINISTERO DELLA SANITA'-DECRETO. Sperimentazione clinica controllata in medicina generale ed in pediatria di libera scelta. 2001. Roma: Gazzetta Ufficiale n. 139 del. 18/06/2001.
5. Roccatagliata D, Roncaglioni C. Rischio & Prevenzione: una nuova proposta di trial clinico in Medicina Generale. Dialogo sui Farmaci 2003; 6: 307-311.
6. Collaborative Group Risk and Prevention Study. How general practitioners perceive and grade the cardiovascular risk of their patients. Eur J Cardiovasc Prev Rehabil 2004; 11: 233-238.
7. Pangrazzi I, Monesi L, Garzona I et al. Il monitoraggio degli studi clinici in Medicina Generale: la proposta di Rischio&Prevenzione e il ruolo dei farmacisti territoriali. GIFC 2005; 19: 2.
8. Monesi L, Avanzini F, Barlera S et al. Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk? Eur J Clin Pharmacol 2005; 61: 595-601.
9. Caimi V. Parte lo studio Rischio&Prevenzione. Occhio Clinico 2004; 1: 39-42.
10. Roccatagliata D, Monesi L, Avanzini F, Roncaglioni C. Risk & prevention. A study on the perception and control of cardiovascular risk in general practice. Ric Prat 2001; 17: 205-221.
11. Roncaglioni C, Marchioli R. Epidemiologia e sperimentazione in un unico studio. Tempo medico Cuore. Numero 2/sett-05Cin2. 2005 9:35: 37-39.